• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Helper
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees for your businessNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Nature's Sunshine Appoints Steven Fasching to Board of Directors

    11/11/24 4:05:00 PM ET
    $DECK
    $NATR
    Shoe Manufacturing
    Consumer Discretionary
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $DECK alert in real time by email

    Steven Fasching, Director

    LEHI, Utah, Nov. 11, 2024 (GLOBE NEWSWIRE) -- Nature's Sunshine Products, Inc. (Nature's Sunshine) (NASDAQ:NATR), a leading manufacturer of high-quality herbal and nutritional supplements, today announced the appointment of Mr. Steven Fasching to its board of directors, effective November 6, 2024. Nature's Sunshine's board will now consist of nine directors with eight serving as independent directors.

    "We are delighted to welcome Steve to our expanded board of directors," said Richard D. Moss, Chairman of the Board for Nature's Sunshine. "He brings significant financial acumen and public company experience from well-known consumer brands and will be a valuable addition to our board. Steve's experience in finance will strengthen our leadership as we continue the transformation of our business."

    Since June 2018, Fasching has served as the Chief Financial Officer of Deckers Brands (NYSE:DECK), which includes iconic brands such as UGG®, Hoka® and Teva®. Fasching has held other senior positions at Deckers Brands since August 2011, including Vice President, Strategy & Investor Relations and Vice President, Strategic Financial Planning. Fasching has over 30 years of experience in long-term financial and strategic planning for multi-billion-dollar organizations. Fasching received a B.S. degree in Business Administration from Pepperdine University and an M.B.A. from The Anderson School of Management at UCLA. He also completed The Executive Program for Prospective Chief Financial Officers through the University of Chicago Booth School of Business.

    About Nature's Sunshine

    Nature's Sunshine Products (NASDAQ:NATR), a leading natural health and wellness company, markets and distributes nutritional and personal care products in more than 40 countries. Nature's Sunshine manufactures most of its products through its own state-of-the-art facilities to ensure its products continue to set the standard for the highest quality, safety, and efficacy on the market today. Additional information about the Company can be obtained at its website, www.naturessunshine.com.

    Investor Relations

    Gateway Group, Inc.

    Cody Slach

    1-949-574-3860

    [email protected]

    A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/851f1698-5928-4576-8d35-745869a4dcdf



    Primary Logo

    Get the next $DECK alert in real time by email

    Crush Q3 2025 with the Best AI Executive Assistant

    Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Tailforce.ai

    Recent Analyst Ratings for
    $DECK
    $NATR

    CompanyDatePrice TargetRatingAnalyst
    Deckers Outdoor Corporation
    $DECK
    7/2/2025$90.00Sell
    Goldman
    Deckers Outdoor Corporation
    $DECK
    6/13/2025Hold
    Argus
    Deckers Outdoor Corporation
    $DECK
    5/23/2025Overweight → Sector Weight
    KeyBanc Capital Markets
    Deckers Outdoor Corporation
    $DECK
    5/23/2025$110.00Outperform → In-line
    Evercore ISI
    Deckers Outdoor Corporation
    $DECK
    5/23/2025$120.00Outperform → Market Perform
    Telsey Advisory Group
    Deckers Outdoor Corporation
    $DECK
    5/21/2025$246.00 → $150.00Buy
    Needham
    Nature's Sunshine Products Inc.
    $NATR
    5/7/2025$19.00Buy
    DA Davidson
    Deckers Outdoor Corporation
    $DECK
    4/10/2025$235.00 → $150.00Outperform → Strong Buy
    Raymond James
    More analyst ratings

    $DECK
    $NATR
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Davis Cindy L bought $200,319 worth of shares (1,825 units at $109.76), increasing direct ownership by 16% to 13,340 units (SEC Form 4)

      4 - DECKERS OUTDOOR CORP (0000910521) (Issuer)

      6/6/25 7:31:48 PM ET
      $DECK
      Shoe Manufacturing
      Consumer Discretionary

    $DECK
    $NATR
    Leadership Updates

    Live Leadership Updates

    See more
    • Nature's Sunshine Announces Leadership Transition Plan

      Board Initiates CEO Search Process Terrence Moorehead to Step Down as President and CEO, Once Successor Appointed Company Reaffirms Full Year 2025 Outlook LEHI, Utah, June 02, 2025 (GLOBE NEWSWIRE) -- Nature's Sunshine Products, Inc. (NASDAQ:NATR) ("Nature's Sunshine") (the "Company"), a leading manufacturer of high-quality herbal and nutritional supplements, today announced that Terrence Moorehead has notified the Company's Board of Directors (the "Board") of his decision to step down as President and Chief Executive Officer, effective upon the appointment of a successor. At that time, Mr. Moorehead will also resign as a member of the Board of Directors. The Nature's Sunshine Board ha

      6/2/25 9:00:00 AM ET
      $NATR
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Deckers Brands Appoints Cynthia L. Davis as Chair of the Board

      Michael F. Devine, III to Retire from the Board After Over 14 Years of Service Deckers Brands (NYSE:DECK), a global leader in designing, marketing, and distributing innovative footwear, apparel, and accessories, today announced the appointment of Cynthia (Cindy) L. Davis as Chair of the Board of Directors (the "Board"), effective immediately. She succeeds Michael (Mike) F. Devine, III, who is retiring from the Board after over 14 years of service, including six years as Chair. Ms. Davis joined the Board in 2018 and has served as Chair of its Talent & Compensation Committee since 2019 and as a member of its Corporate Responsibility, Sustainability & Governance Committee since 2021. She bri

      5/22/25 4:06:00 PM ET
      $DECK
      Shoe Manufacturing
      Consumer Discretionary
    • Nature's Sunshine Appoints Heidi Wissmiller as Chairman of the Board

      LEHI, Utah, May 05, 2025 (GLOBE NEWSWIRE) -- Nature's Sunshine Products, Inc. (NASDAQ:NATR), a leading natural health and wellness company of high-quality herbal and nutritional products, today announced the appointment of Heidi Wissmiller as Chairman of the Board of Directors, effective April 30, 2025. She succeeds Richard D. Moss, who has retired after serving as a Director since 2018 and Chairman since 2022. Ms. Wissmiller has served on the Board of Nature's Sunshine since 2020. Over the course of her tenure, she has chaired the Governance and Risk Management Committees. As Chief Growth Officer at Rodan + Fields ("R+F"), the leading skincare brand in North America, Ms. Wissmiller led

      5/5/25 8:00:00 AM ET
      $NATR
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $DECK
    $NATR
    Financials

    Live finance-specific insights

    See more
    • Deckers Brands Reports Fourth Quarter and Full Fiscal Year 2025 Financial Results

      FY 2025 Revenue Increased 16% to a Record $4.99 Billion FY 2025 Diluted EPS Increased 30% to a Record $6.33 Share Repurchase Authorization Increased to $2.5 Billion Deckers Brands (NYSE:DECK), a global leader in designing, marketing, and distributing innovative footwear, apparel, and accessories, today announced financial results for the fourth fiscal quarter and full fiscal year ended March 31, 2025. The Company also provided its financial outlook for the first fiscal quarter ending June 30, 2025. "Deckers delivered another exceptional year of results in fiscal 2025, highlighted by the HOKA and UGG brands' respective revenue growth of 24% and 13%, as well as record earnings per sha

      5/22/25 4:05:00 PM ET
      $DECK
      Shoe Manufacturing
      Consumer Discretionary
    • Deckers Brands Announces Conference Call to Review Fourth Quarter and Full Fiscal Year 2025 Earnings Results

      Deckers Brands (NYSE:DECK), a global leader in designing, marketing and distributing innovative footwear, apparel and accessories, today announced that the Company's conference call to review fourth quarter and full fiscal year 2025 results will be on Thursday, May 22, 2025 at approximately 4:30 pm Eastern Time. The broadcast will be hosted at ir.deckers.com. The broadcast will be available for at least 30 days following the conference call. About Deckers Brands Deckers Brands is a global leader in designing, marketing, and distributing innovative footwear, apparel, and accessories developed for both everyday casual lifestyle use and high-performance activities. The Company's portfolio of

      5/12/25 4:05:00 PM ET
      $DECK
      Shoe Manufacturing
      Consumer Discretionary
    • Nature's Sunshine Reports Strong First Quarter 2025 Results

      LEHI, Utah, May 06, 2025 (GLOBE NEWSWIRE) -- Nature's Sunshine Products, Inc. (NASDAQ:NATR) ("Nature's Sunshine"), a leading manufacturer of high-quality herbal and nutritional supplements, reported financial results for the first quarter ended March 31, 2025. First Quarter 2025 Financial Summary vs. Same Year-Ago Quarter Net sales were up 2% to $113.2 million compared to $111.0 million (up 5% in constant currency).GAAP net income attributable to common shareholders was up 104% to $4.7 million, or $0.25 per diluted common share, compared to $2.3 million, or $0.12 per diluted common share.Adjusted EBITDA was up 20% to $11.0 million compared to $9.2 million. Capital Allocation Na

      5/6/25 4:05:00 PM ET
      $NATR
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $DECK
    $NATR
    SEC Filings

    See more
    • SEC Form 8-K filed by Nature's Sunshine Products Inc.

      8-K - NATURES SUNSHINE PRODUCTS INC (0000275053) (Filer)

      6/27/25 8:31:04 AM ET
      $NATR
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form 424B5 filed by Nature's Sunshine Products Inc.

      424B5 - NATURES SUNSHINE PRODUCTS INC (0000275053) (Filer)

      6/27/25 7:23:14 AM ET
      $NATR
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form 424B5 filed by Nature's Sunshine Products Inc.

      424B5 - NATURES SUNSHINE PRODUCTS INC (0000275053) (Filer)

      6/25/25 4:01:22 PM ET
      $NATR
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $DECK
    $NATR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by Deckers Outdoor Corporation (Amendment)

      SC 13G/A - DECKERS OUTDOOR CORP (0000910521) (Subject)

      4/10/24 2:03:52 PM ET
      $DECK
      Shoe Manufacturing
      Consumer Discretionary
    • SEC Form SC 13G/A filed by Deckers Outdoor Corporation (Amendment)

      SC 13G/A - DECKERS OUTDOOR CORP (0000910521) (Subject)

      2/13/24 5:02:34 PM ET
      $DECK
      Shoe Manufacturing
      Consumer Discretionary
    • SEC Form SC 13G/A filed by Nature's Sunshine Products Inc. (Amendment)

      SC 13G/A - NATURES SUNSHINE PRODUCTS INC (0000275053) (Subject)

      2/12/24 10:37:49 AM ET
      $NATR
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $DECK
    $NATR
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Introducing the Rocket X 3: a New Race Day Icon Engineered for Speed

      The highly anticipated update of the Rocket X franchise delivers innovative performance solutions without sacrificing comfort and stability. HOKA®, a division of Deckers Brands (NYSE:DECK), introduces the Rocket X 3, a race-day shoe designed to help runners reach personal bests. The Rocket X 3 delivers speed, long-haul comfort, and race-day stability for runners looking to conquer their next road race. The Rocket X 3 is available now on HOKA.com and authorized dealers worldwide. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250701032296/en/ AHEAD OF YOUR TIME Designed for runners looking for peak performance, the Rocket X 3

      7/1/25 9:00:00 AM ET
      $DECK
      Shoe Manufacturing
      Consumer Discretionary
    • Nature's Sunshine Products, Inc. Announces Pricing of Secondary Public Offering of Common Stock

      LEHI, Utah, June 26, 2025 (GLOBE NEWSWIRE) -- Nature's Sunshine Products, Inc. (NASDAQ:NATR) ("Nature's Sunshine" or the "Company"), a leading manufacturer of high-quality herbal and nutritional supplements, today announced the pricing of an underwritten secondary public offering of up to 2,854,607 shares of its common stock to be sold by Fosun Pharma USA, Inc (the "Selling Stockholder"). The shares of common stock are being sold at a price of $12.00 per share. The offering is expected to close on June 27, 2025, subject to customary closing conditions. The Selling Stockholder will receive all of the net proceeds from the offering. Nature's Sunshine is not selling any shares of common stoc

      6/26/25 6:30:00 AM ET
      $NATR
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Nature's Sunshine Products, Inc. Announces Launch of Secondary Public Offering of Common Stock

      LEHI, Utah, June 25, 2025 (GLOBE NEWSWIRE) -- Nature's Sunshine Products, Inc. (NASDAQ:NATR) ("Nature's Sunshine" or the "Company"), a leading manufacturer of high-quality herbal and nutritional supplements, today announced the launch of an underwritten secondary public offering of up to 2,854,607 shares of its common stock to be sold by Fosun Pharma USA, Inc (the "Selling Stockholder"). The Selling Stockholder will receive all of the net proceeds from the offering. Nature's Sunshine is not selling any shares of common stock in the offering and will not receive any proceeds from the offering. The Selling Stockholder will pay any underwriting discounts and commissions and transfer taxes at

      6/25/25 4:01:00 PM ET
      $NATR
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $DECK
    $NATR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Goldman initiated coverage on Deckers Outdoor with a new price target

      Goldman initiated coverage of Deckers Outdoor with a rating of Sell and set a new price target of $90.00

      7/2/25 7:56:46 AM ET
      $DECK
      Shoe Manufacturing
      Consumer Discretionary
    • Argus initiated coverage on Deckers Outdoor

      Argus initiated coverage of Deckers Outdoor with a rating of Hold

      6/13/25 8:07:11 AM ET
      $DECK
      Shoe Manufacturing
      Consumer Discretionary
    • Deckers Outdoor downgraded by KeyBanc Capital Markets

      KeyBanc Capital Markets downgraded Deckers Outdoor from Overweight to Sector Weight

      5/23/25 8:15:18 AM ET
      $DECK
      Shoe Manufacturing
      Consumer Discretionary

    $DECK
    $NATR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Large owner Shanghai Fosun Pharmaceutical (Group) Co., Ltd. sold $32,713,796 worth of shares (2,854,607 units at $11.46) (SEC Form 4)

      4 - NATURES SUNSHINE PRODUCTS INC (0000275053) (Issuer)

      6/27/25 4:27:23 PM ET
      $NATR
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • New insider Fosun Pharma Usa Inc. claimed ownership of 2,854,607 shares (SEC Form 3)

      3 - NATURES SUNSHINE PRODUCTS INC (0000275053) (Issuer)

      6/9/25 4:32:08 PM ET
      $NATR
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Director Ibrahim Maha Saleh sold $32,723 worth of shares (300 units at $109.08), decreasing direct ownership by 3% to 10,681 units (SEC Form 4)

      4 - DECKERS OUTDOOR CORP (0000910521) (Issuer)

      6/6/25 8:30:54 PM ET
      $DECK
      Shoe Manufacturing
      Consumer Discretionary